Stocks · News reference

8-K filing — ACCENDRA HEALTH INC/VA/ (ACH)

Aug 17, 2026, 10:42 AMSEC EDGAR

Filed: 2026-08-17 AccNo: 0001104659-26-097517 Size: 203 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 17, 2026, 10:36 AMBenzinga Newsdesk
Accendra Health Updates Capital Plans; Nets $45M From Non-Core Asset Sales And Sets CEO Succession Timeline For September
Accendra Health (the "Company") is providing an update on its capital allocation plans and the timeline for the replacement of its chief executive officer.Given recent market conditions, the Company has
Read original at benzinga
ACH
BenzingaAug 13, 2026, 9:11 PMBenzinga Newsdesk
UBS Maintains Neutral on Accendra Health, Lowers Price Target to $1.5
UBS analyst Kevin Caliendo maintains Accendra Health (NYSE:ACH) with a Neutral and lowers the price target from $4.5 to $1.5.
Read original at benzinga
ACH
BenzingaAug 11, 2026, 2:17 PMBenzinga Newsdesk
Accendra Health shares are trading lower after Citigroup downgraded the stock from Buy to Neutral rating and lowered the price target from $4.5 to $1.5.
Read original at benzinga
ACH